AAAAAA
Results:
1-23
|
Results: 23
Authors:
DAWSON DM
LAWRENCE EG
MACLENNAN GT
AMINI SB
KUNG HJ
ROBINSON D
RESNICK MI
KURSH ED
PRETLOW TP
PRETLOW TG
Citation: Dm. Dawson et al., ALTERED EXPRESSION OF RET PROTOONCOGENE PRODUCT IN PROSTATIC INTRAEPITHELIAL NEOPLASIA AND PROSTATE-CANCER, Journal of the National Cancer Institute, 90(7), 1998, pp. 519-523
Authors:
PRETLOW TP
PRETLOW TG
Citation: Tp. Pretlow et Tg. Pretlow, PUTATIVE PRENEOPLASTIC CHANGES IDENTIFIED BY ENZYME-HISTOCHEMICAL ANDIMMUNOHISTOCHEMICAL TECHNIQUES, The Journal of histochemistry and cytochemistry, 46(5), 1998, pp. 577-583
Authors:
SIU IM
PRETLOW TG
AMINI SB
PRETLOW TP
Citation: Im. Siu et al., IDENTIFICATION OF DYSPLASIA IN HUMAN COLONIC ABERRANT CRYPT FOCI, The American journal of pathology, 150(5), 1997, pp. 1805-1813
Authors:
AUGENLICHT LH
RICHARDS C
CORNER G
PRETLOW TP
Citation: Lh. Augenlicht et al., EVIDENCE FOR GENOMIC INSTABILITY IN HUMAN COLONIC ABERRANT CRYPT FOCI, Oncogene, 12(8), 1996, pp. 1767-1772
Authors:
PRETLOW TG
PRETLOW TP
Citation: Tg. Pretlow et Tp. Pretlow, ANDROGEN-DEPENDENT PROSTATE-CANCER XENOGRAFT AND RELAPSED STRAINS, The FASEB journal, 10(6), 1996, pp. 837-837
Authors:
WHITELEY LO
HUDSON L
PRETLOW TP
Citation: Lo. Whiteley et al., ABERRANT CRYPT FOCI IN THE COLONIC MUCOSA OF RATS TREATED WITH A GENOTOXIC AND NONGENOTOXIC COLON CARCINOGEN, Toxicologic pathology, 24(6), 1996, pp. 681-689
Authors:
KONSTANTAKOS AK
SIU IM
PRETLOW TG
STELLATO TA
PRETLOW TP
Citation: Ak. Konstantakos et al., HUMAN ABERRANT CRYPT FOCI WITH CARCINOMA IN-SITU FROM A PATIENT WITH SPORADIC COLON-CANCER, Gastroenterology, 111(3), 1996, pp. 772-777
Authors:
FENG Y
WAGNER RJ
FRETLAND AJ
BECKER WK
COOLEY AM
PRETLOW TP
LEE KJ
HEIN DW
Citation: Y. Feng et al., ACETYLATOR GENOTYPE (NAT2)-DEPENDENT FORMATION OF ABERRANT CRYPTS IN CONGENIC SYRIAN-HAMSTERS ADMINISTERED 3,2'-DIMETHYL-4-AMINOBIPHENYL, Cancer research, 56(3), 1996, pp. 527-531
Authors:
NAGABHUSHAN M
MILLER CM
PRETLOW TP
GIACONIA JM
EDGEHOUSE NL
SCHWARTZ S
KUNG HJ
WHITE RWD
GUMERLOCK PH
RESNICK MI
AMINI SB
PRETLOW TG
Citation: M. Nagabhushan et al., CWR22 - THE FIRST HUMAN PROSTATE-CANCER XENOGRAFT WITH STRONGLY ANDROGEN-DEPENDENT RELAPSED STRAINS BOTH IN-VIVO AND IN SOFT AGAR, Cancer research, 56(13), 1996, pp. 3042-3046
Authors:
CHENG L
NAGABHUSHAN M
PRETLOW TP
AMINI SB
PRETLOW TG
Citation: L. Cheng et al., EXPRESSION OF E-CADHERIN IN PRIMARY AND METASTATIC PROSTATE-CANCER, The American journal of pathology, 148(5), 1996, pp. 1375-1380
Authors:
NAGABHUSHAN M
PRETLOW TG
GUO YJ
AMINI SB
PRETLOW TP
SY MS
Citation: M. Nagabhushan et al., ALTERED EXPRESSION OF CD44 IN HUMAN PROSTATE-CANCER DURING PROGRESSION, American journal of clinical pathology, 106(5), 1996, pp. 647-651
Authors:
PRETLOW TG
YANG B
PRETLOW TP
Citation: Tg. Pretlow et al., ORGAN-CULTURE OF BENIGN, AGING, AND HYPERPLASTIC HUMAN PROSTATE, Microscopy research and technique, 30(4), 1995, pp. 271-281
Authors:
PRETLOW TG
NAGABHUSHAN M
PRETLOW TP
Citation: Tg. Pretlow et al., PROSTATIC INTRAEPITHELIAL NEOPLASIA AND OTHER CHANGES DURING PROMOTION AND PROGRESSION, Pathology research and practice, 191(9), 1995, pp. 842-849
Authors:
ZAIDI NH
PRETLOW TP
ORIORDAN MA
DUMENCO LL
ALLAY E
GERSON SL
Citation: Nh. Zaidi et al., TRANSGENIC EXPRESSION OF HUMAN MGMT PROTECTS AGAINST AZOXYMETHANE-INDUCED ABERRANT CRYPT FOCI AND G-TO-A MUTATIONS IN THE K-RAS ONCOGENE OFMOUSE COLON, Carcinogenesis, 16(3), 1995, pp. 451-456
Authors:
PRETLOW TP
Citation: Tp. Pretlow, ABERRANT CRYPT FOCI AND K-RAS MUTATIONS - EARLIEST RECOGNIZED PLAYERSOR INNOCENT BYSTANDERS IN COLON CARCINOGENESIS, Gastroenterology, 108(2), 1995, pp. 600-603
Authors:
PRETLOW TG
NAGABHUSHAN M
SY M
GUO YJ
PRETLOW TP
Citation: Tg. Pretlow et al., PUTATIVE PRENEOPLASTIC FOCI IN THE HUMAN PROSTATE, Journal of cellular biochemistry, 1994, pp. 224-231
Authors:
PRETLOW TP
CHEYER C
ORIORDAN MA
Citation: Tp. Pretlow et al., ABERRANT CRYPT FOCI AND COLON TUMORS IN F344 RATS HAVE SIMILAR INCREASES IN PROLIFERATIVE ACTIVITY, International journal of cancer, 56(4), 1994, pp. 599-602
Authors:
PRETLOW TP
ROUKHADZE EV
ORIORDAN MA
CHAN JC
AMINI SB
STELLATO TA
Citation: Tp. Pretlow et al., CARCINOEMBRYONIC ANTIGEN IN HUMAN COLONIC ABERRANT CRYPT FOCI, Gastroenterology, 107(6), 1994, pp. 1719-1725
Authors:
WAINSTEIN MA
HE F
ROBINSON D
KUNG HJ
SCHWARTZ S
GIACONIA JM
EDGEHOUSE NL
PRETLOW TP
BODNER DR
KURSH ED
RESNICK MI
SEFTEL A
PRETLOW TG
Citation: Ma. Wainstein et al., CWR22 - ANDROGEN-DEPENDENT XENOGRAFT MODEL DERIVED FROM A PRIMARY HUMAN PROSTATIC-CARCINOMA, Cancer research, 54(23), 1994, pp. 6049-6052
Authors:
MONGER LE
NAGABHUSHAN M
PRETLOW TG
PRETLOW TP
Citation: Le. Monger et al., A NOVEL-APPROACH TO THE CHARACTERIZATION OF WHOLE PROSTATE PATHOLOGY IN GLYCOL METHACRYLATE, The American journal of pathology, 145(1), 1994, pp. 54-60
Authors:
PRETLOW TP
BRASITUS TA
FULTON NC
CHEYER C
KAPLAN EL
Citation: Tp. Pretlow et al., K-RAS MUTATIONS IN PUTATIVE PRENEOPLASTIC LESIONS IN HUMAN COLON, Journal of the National Cancer Institute, 85(24), 1993, pp. 2004-2007
Authors:
PRETLOW TG
OGRINC GS
AMINI SB
DELMORO CM
MOLKENTIN KF
WILLSON JKV
PRETLOW TP
Citation: Tg. Pretlow et al., A BETTER DEFINED MEDIUM FOR HUMAN PROSTATE-CANCER CELLS, In vitro cellular & developmental biology. Animal, 29A(7), 1993, pp. 528-530
Authors:
PRETLOW TP
ORIORDAN MA
SPANCAKE KM
PRETLOW TG
Citation: Tp. Pretlow et al., 2 TYPES OF PUTATIVE PRENEOPLASTIC LESIONS IDENTIFIED BY HEXOSAMINIDASE ACTIVITY IN WHOLE-MOUNTS OF COLONS FROM F344 RATS TREATED WITH CARCINOGEN, The American journal of pathology, 142(6), 1993, pp. 1695-1700
Risultati:
1-23
|